SIAC
:Type 1 and 2 diabetes
:Phase 3
SIAC is a neutral, soluble, dual-acting new generation of insulin with improved properties and potential duration of action above 24 hours.
- Company announcements
- No company announcements matching the search criteria
- Press releases
- No press releases matching the search criteria
- Scientific abstracts
No scientific abstracts matching the search criteria
